GraceFinance · Source-backed public company research
Microbot Medical Inc. (MBOT)
Nasdaq · Manufacturing · Surgical & Medical Instruments & Apparatus
Core research established · 4/4 core data layers currently established
What Microbot Medical Inc. does
strategy in part relies on identifying, acquiring and developing complementary technologies and products, which entails risks which could negatively affect our business, operations and financial condition. We have in the past and may again in the future pursue other acquisitions of businesses and technologies. Acquisitions entail numerous risks, including: ● difficulties in the integration of acquired operations, services and products; ● failure to achieve expected synergies; ● diversion of management’s attention from other business concerns; ● assumption of unknown material liabilities of acquired companies; ● amortization of acquired intangible assets, which could reduce future reported earnings; ● Lack of funding to properly and adequately develop and commercialize the technologies acquired; ● potential loss of clients or key employees…
Open the company story
The live GraceFinance page shows source-backed financial changes, management context, guidance, confirmed events, risks, and connected history only when the applicable evidence and relationships have been established. Missing research stays visible instead of being inferred.